Multidrug Resistant Gram-negative Bacilli Colonization and Infection in Burn
NCT02653157 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48
Last updated 2018-10-12
Summary
This is a prospective observational study to determine the role of colonization and identify the timing of development of drug resistance in multidrug resistant Gram-negative bacilli (MDR-GNB) causing infection among critically ill burn patients.
Conditions
- Multi-drug Resistant Gram-negative Bacilli Colonization
Interventions
- OTHER
-
MDR-GNB
Sponsors & Collaborators
-
North Carolina Translational and Clinical Sciences Institute
collaborator OTHER -
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Anne Lachiewicz, MD, MPH · University of North Carolina, Chapel Hill
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2017-06-30
- Completion
- 2017-12-31
Countries
- United States
Study Locations
More Related Trials
-
Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children
NCT04535661 ·Status: RECRUITING
-
Predictors of Rates of Resistant Gram-Negative Bacteria
NCT01075009 ·Status: COMPLETED
-
Multi-resistant and Spore-forming Bacteria in a Neonatal Intensive Care Unit
NCT06391463 ·Status: ENROLLING_BY_INVITATION
-
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
NCT01597973 ·Status: COMPLETED ·Phase: PHASE3
-
Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa
NCT06738771 ·Status: RECRUITING
-
Wound Bacterial Microbiota and Their Antibiotic Resistance
NCT02744144 ·Status: COMPLETED
-
ICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients
NCT04043793 ·Status: COMPLETED
-
A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting
NCT04516148 ·Status: COMPLETED ·Phase: PHASE4
-
Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant Pathogens
NCT03159078 ·Status: UNKNOWN ·Phase: PHASE3
-
Turkish Prospective Cohort Study on Carbapenem Resistant Klebsiella Pneumonia Bacteremia
NCT03597841 ·Status: COMPLETED
-
NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria
NCT05017766 ·Status: RECRUITING
-
A Study on the Prophylactic Use of Antibiotics Within 72 Hours After Acute Burn Injury in Patients
NCT06221761 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized Patients
NCT04229511 ·Status: UNKNOWN
-
Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection
NCT02482961 ·Status: COMPLETED
-
Peripheral Venous Catheter Related Blood Stream Infections
NCT05139628 ·Status: UNKNOWN
-
Population Pharmacokinetic Study of Colistin in Patients Infected With Multiresistant Gram-negative Bacteria
NCT01060891 ·Status: COMPLETED ·Phase: PHASE1
-
Bacterial Decolonization Within Dyads
NCT06541145 ·Status: RECRUITING ·Phase: NA
-
Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin
NCT00414362 ·Status: COMPLETED
-
Therapy of Ventilator-associated Tracheobronchitis Caused by Gram Negative Bacteria With Nebulized Colistin
NCT02619786 ·Status: UNKNOWN ·Phase: PHASE3
-
Fecal Microbiota Transplantation in Patients With Multiple Drug Resistant Klebsiella Pneumoniae Pneumonia
NCT06641778 ·Status: RECRUITING ·Phase: NA
-
Comparative Effectiveness and Cost-Benefit Analysis of Vancomycin Powder in High Risk Spine Surgery Patients
NCT01566422 ·Status: WITHDRAWN ·Phase: NA
-
Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations
NCT04573894 ·Status: COMPLETED
-
Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections
NCT05942157 ·Status: RECRUITING ·Phase: NA
-
Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
NCT05210387 ·Status: TERMINATED ·Phase: NA
-
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China
NCT03245632 ·Status: UNKNOWN